Search research articles
Contact Us
Filters
Showing results (131-140 of 155) with videos related to
Page
of 16
Sort By:
Therapeutic Advances in Medical Oncology
|
March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
Isabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Urology Focus
|
March 23, 2022
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer
Igor Tsaur, Roderick C N van den Bergh, Timo Soeterik, et al.
European Urology
|
April 10, 2020
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection
Giorgio Gandaglia, Alberto Martini, Guillaume Ploussard, et al.
European Urology Oncology
|
September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review
Giancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
Molecular Cancer
|
May 4, 2025
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
Emine Atas, Kerstin Berchtold, Michaela Schlederer, et al.
European Radiology
|
April 30, 2025
Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysis
Filippo Carletti, Martina Maggi, Tamas Fazekas, et al.
Molecular Cancer
|
June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Isabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Current Opinion in Urology
|
November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence
Charles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
European Urology
|
May 29, 2024
Challenging the Urologist of the Future: Time for a Change?
Fabian P Stangl, Isabel Heidegger, Pia Kraft, et al.
Cancers
|
January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives
Alexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 155) with videos related to
Sort By:
Page
of 16
Therapeutic Advances in Medical Oncology
|
March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
Isabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Urology Focus
|
March 23, 2022
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer
Igor Tsaur, Roderick C N van den Bergh, Timo Soeterik, et al.
European Urology
|
April 10, 2020
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection
Giorgio Gandaglia, Alberto Martini, Guillaume Ploussard, et al.
European Urology Oncology
|
September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review
Giancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
Molecular Cancer
|
May 4, 2025
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
Emine Atas, Kerstin Berchtold, Michaela Schlederer, et al.
European Radiology
|
April 30, 2025
Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysis
Filippo Carletti, Martina Maggi, Tamas Fazekas, et al.
Molecular Cancer
|
June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Isabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Current Opinion in Urology
|
November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence
Charles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
European Urology
|
May 29, 2024
Challenging the Urologist of the Future: Time for a Change?
Fabian P Stangl, Isabel Heidegger, Pia Kraft, et al.
Cancers
|
January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives
Alexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
Page
of 16